1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    





















































































































    Enhancing Fraction in Glioma and Its Relationship to the Tumoral Vascular Microenvironment: A Dynamic Contrast-Enhanced MR Imaging Study | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      
Open Access

  
      
Enhancing Fraction in Glioma and Its Relationship to the Tumoral Vascular Microenvironment: A Dynamic Contrast-Enhanced MR Imaging Study
  
    	
S.J. Mills, C. Soh, J.P.B. O'Connor, C.J. Rose, G. Buonaccorsi, S. Cheung, S. Zhao, G.J.M. Parker and A. Jackson

  
    	
American Journal of Neuroradiology April 2010,  31 (4) 726-731; DOI: https://doi.org/10.3174/ajnr.A1925 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Evelhoch  JL
    . Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999; 10: 254–59
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. Roberts  C, 
    2. Issa  B, 
    3. Stone  A, 
    4. et al
    . Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006; 23: 554–63
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Tofts  PS
    . Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91–101
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. Aronen  HJ, 
    2. Gazit  IE, 
    3. Louis  DN, 
    4. et al
    . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41–51
    PubMedWeb of Science
  5. 5.↵


    1. Aronen  HJ, 
    2. Glass  J, 
    3. Pardo  FS, 
    4. et al
    . Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 1995; 36: 520–28
    Abstract/FREE Full Text
  6. 6.↵


    1. Aronen  HJ, 
    2. Pardo  FS, 
    3. Kennedy  DN, 
    4. et al
    . High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000; 6: 2189–200
    Abstract/FREE Full Text
  7. 7.↵


    1. Knopp  EA, 
    2. Cha  S, 
    3. Johnson  G, 
    4. et al
    . Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211: 791–98
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Lam  WW, 
    2. Chan  KW, 
    3. Wong  WL, 
    4. et al
    . Pre-operative grading of intracranial glioma. Acta Radiol 2001; 42: 548–54
    FREE Full Text
  9. 9.↵


    1. Law  M, 
    2. Yang  S, 
    3. Babb  JS, 
    4. et al
    . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004; 25: 746–55
    Abstract/FREE Full Text
  10. 10.↵


    1. Law  M, 
    2. Yang  S, 
    3. Wang  H, 
    4. et al
    . Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989–98
    Abstract/FREE Full Text
  11. 11.↵


    1. Lev  MH, 
    2. Ozsunar  Y, 
    3. Henson  JW, 
    4. et al
    . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 2004; 25: 214–21
    Abstract/FREE Full Text
  12. 12.↵


    1. Sadeghi  N, 
    2. Salmon  I, 
    3. Decaestecker  C, 
    4. et al
    . Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am J Neuroradiol 2007; 28: 455–61
    Abstract/FREE Full Text
  13. 13.↵


    1. Patankar  TF, 
    2. Haroon  HA, 
    3. Mills  SJ, 
    4. et al
    . Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas? AJNR Am J Neuroradiol 2005; 26: 2455–65
    Abstract/FREE Full Text
  14. 14.↵


    1. Ludemann  L, 
    2. Grieger  W, 
    3. Wurm  R, 
    4. et al
    . Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging 2005; 23: 833–41
    CrossRefPubMed
  15. 15.↵


    1. Cha  S, 
    2. Tihan  T, 
    3. Crawford  F, 
    4. et al
    . Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005; 26: 266–73
    Abstract/FREE Full Text
  16. 16.↵


    1. Law  M, 
    2. Brodsky  JE, 
    3. Babb  J, 
    4. et al
    . High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: preliminary results of molecular studies in gliomas with elevated perfusion. J Magn Reson Imaging 2007; 25: 1113–19
    CrossRefPubMed
  17. 17.↵


    1. Jenkinson  MD, 
    2. Smith  TS, 
    3. Joyce  KA, 
    4. et al
    . Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours. Neuroradiology 2006; 48: 703–13. 
Epub 2006 Aug 26
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. Cha  S, 
    2. Yang  L, 
    3. Johnson  G, 
    4. et al
    . Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol 2006; 27: 409–17
    Abstract/FREE Full Text
  19. 19.↵


    1. Provenzale  JM, 
    2. Wang  GR, 
    3. Brenner  T, 
    4. et al
    . Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002; 178: 711–16
    CrossRefPubMedWeb of Science
  20. 20.↵


    1. Roberts  HC, 
    2. Roberts  TP, 
    3. Brasch  RC, 
    4. et al
    . Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21: 891–99
    Abstract/FREE Full Text
  21. 21.↵


    1. Cao  Y, 
    2. Tsien  CI, 
    3. Nagesh  V, 
    4. et al
    . Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys 2006; 64: 876–85
    CrossRefPubMedWeb of Science
  22. 22.↵


    1. Law  M, 
    2. Oh  S, 
    3. Johnson  G, 
    4. et al
    . Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery 2006; 58: 1099–107
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. Mills  SJ, 
    2. Patankar  TA, 
    3. Haroon  HA, 
    4. et al
    . Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006; 27: 853–58
    Abstract/FREE Full Text
  24. 24.↵


    1. Law  M, 
    2. Oh  S, 
    3. Babb  JS, 
    4. et al
    . Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology 2006; 238: 658–67
    CrossRefPubMedWeb of Science
  25. 25.↵


    1. Law  M, 
    2. Young  RJ, 
    3. Babb  JS, 
    4. et al
    . Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008; 247: 490–98
    CrossRefPubMedWeb of Science
  26. 26.↵


    1. Jayson  GC, 
    2. Parker  GJ, 
    3. Mullamitha  S, 
    4. et al
    . Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab′, leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol 2005; 23: 973–81. 
Epub 2004 Oct 4
    Abstract/FREE Full Text
  27. 27.↵


    1. Mullamitha  SA, 
    2. Ton  NC, 
    3. Parker  GJ, 
    4. et al
    . Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin Cancer Res 2007; 13: 2128–35
    Abstract/FREE Full Text
  28. 28.↵


    1. O'Connor  JP, 
    2. Jayson  GC, 
    3. Jackson  A, 
    4. et al
    . Enhancing fraction predicts clinical outcome following first-line chemotherapy in patients with epithelial ovarian carcinoma. Clin Cancer Res 2007; 13: 6130–35
    Abstract/FREE Full Text
  29. 29.↵


    1. Mills  SJ, 
    2. Soh  C, 
    3. O'Connor  JP, 
    4. et al
    . Tumour enhancing fraction (EnF) in glioma: relationship to tumour grade. Eur Radiol 2009; 19: 1489–98
    CrossRefPubMed
  30. 30.↵


    1. Louis  DN, 
    2. Ohgaki  H, 
    3. Wiestler  OD, 
    4. et al
    . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97–109. 
Epub 2007 Jul 6
    CrossRefPubMedWeb of Science
  31. 31.↵


    1. Thompson  G, 
    2. Cain  J, 
    3. Jackson  A, 
    4. et al
    . Interobserver agreement for cerebral glioma volumetrics on conventional MR imaging. In: Proceedings of the 16th Annual Scientific Meeting and Exhibition of the International Society of Magnetic Resonance in Medicine, Toronto, Ontario, Canada. May 3–9, 2008
  32. 32.↵


    1. Parker  GJM, 
    2. Jackson  A, 
    3. Waterton  JC, 
    4. et al
    . Automated arterial input function extraction for T1-weighted DCE-MRI. In: Proceedings of the 11th Annual Scientific Meeting and Exhibition of the International Society of Magnetic Resonance in Medicine, Toronto, Ontario, Canada. July 10–16, 2003
  33. 33.↵


    1. Parker  GJM, 
    2. Buckley  DL
    . Tracer Kinetic Modelling for T1-Weighted DCE-MRI. Berlin: Springer-Verlag; 2005: 81–92
  34. 34.↵


    1. Norden  AD, 
    2. Young  GS, 
    3. Setayesh  K, 
    4. et al
    . Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology 2008; 70: 779–87
    CrossRef
  35. 35.↵


    1. Sathornsumetee  S, 
    2. Reardon  DA, 
    3. Desjardins  A, 
    4. et al
    . Molecularly targeted therapy for malignant glioma. Cancer 2007; 110: 13–24
    CrossRefPubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Enhancing Fraction in Glioma and Its Relationship to the Tumoral Vascular Microenvironment: A Dynamic Contrast-Enhanced MR Imaging Study
  
    	
S.J. Mills, C. Soh, J.P.B. O'Connor, C.J. Rose, G. Buonaccorsi, S. Cheung, S. Zhao, G.J.M. Parker, A. Jackson

  
    	
 American Journal of Neuroradiology Apr 2010, 31 (4) 726-731; DOI: 10.3174/ajnr.A1925 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement